Showing 1 - 9 of 9
The workshop addressed a variety of issues, including the magnitude of the pharmaceuticals market and the amounts of pharmaceutically active substances produced; the pathways by which active substances enter the environment; detected or assumed environmental effects; and ways to reduce impacts....
Persistent link: https://www.econbiz.de/10009640781
Persistent link: https://www.econbiz.de/10009640917
European legislation regulating the marketing authorisation of medical products states that results from clinical trials that do not meet the ethical requirements of Good Clinical Practice, cannot legally be used by an applicant to justify its application, irrespective of whether the trial was...
Persistent link: https://www.econbiz.de/10010487943
After the switch to a floating exchange rate in 1973, the Swiss National Bank at first adopted annual monetary targets and in the 1990s shifted to a medium-term targeting strategy. In this paper I review the SNBu0092s internal policy analysis, an aspect of Swiss monetary targeting that has...
Persistent link: https://www.econbiz.de/10009635971
Persistent link: https://www.econbiz.de/10009637809
Persistent link: https://www.econbiz.de/10009637810
Persistent link: https://www.econbiz.de/10009640951
Persistent link: https://www.econbiz.de/10010236741
With the development towards comprehensive and more sophisticated border control regimes, the problem of protection seekers’ access to EU territory has increasingly come into focus. Disorderly movement is presently the main avenue to safety in the EU, and human smugglers act as important...
Persistent link: https://www.econbiz.de/10011799462